Phoenix Biotech Acquisition Corp.
PBAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,022 | $3,303 | $5,204 | $3,327 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $532 | $944 | $564 | $387 |
| Total Curr. Assets | $2,554 | $4,247 | $5,768 | $3,714 |
| Property Plant & Equip (Net) | $1,183 | $1,456 | $1,723 | $1,993 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $175 | $500 | $500 | $500 |
| Total NC Assets | $1,357 | $1,956 | $2,223 | $2,493 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,911 | $6,202 | $7,991 | $6,207 |
| Liabilities | – | – | – | – |
| Payables | $7,077 | $6,213 | $6,379 | $4,507 |
| Short-Term Debt | $931 | $934 | $905 | $876 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $446 | $471 | $575 | -$2,489 |
| Total Curr. Liab. | $8,455 | $7,618 | $7,859 | $7,402 |
| LT Debt | $0 | $218 | $462 | $699 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $218 | $462 | $699 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $8,455 | $7,836 | $8,321 | $8,101 |
| Equity | – | – | – | – |
| Pref Stock | $2 | $47 | $982 | $1,250 |
| Common Stock | $86 | $86 | $86 | $86 |
| Retained Earnings | -$86,297 | -$81,441 | -$76,024 | -$70,918 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $81,669 | $79,722 | $75,608 | $68,938 |
| Total Equity | -$4,543 | -$1,634 | -$329 | -$1,895 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,911 | $6,202 | $7,991 | $6,207 |
| Net Debt | -$1,091 | -$2,150 | -$3,837 | -$1,752 |